Collectively, this study has revealed the little‐known mechanism of m6A participating in atherosclerosis by regulating lncRNA expression and demonstrated that targeted inhibition of METTL3 and H19 is a potential treatment strategy for atherosclerosis. This evidence concerns the gene METTL3 and atherosclerosis.